MICHEL GERARD J 4
4 · Beta Bionics, Inc. · Filed May 26, 2026
Research Summary
AI-generated summary of this filing
Beta Bionics (BBNX) Director Michel Gerard Receives 16,965-Share Award
What Happened
- Director Michel Gerard received a grant of 16,965 restricted stock units (RSUs) on May 21, 2026. The reported acquisition price is $0.00, so the immediate cash value recorded in the Form 4 is $0. These RSUs were granted under the issuer's 2025 Equity Incentive Plan (see footnote).
Key Details
- Transaction date: 2026-05-21; Report filed: 2026-05-26 (Form 4 accession 0001235644-26-000008).
- Transaction type/code: A — Award/Grant (restricted stock unit award).
- Shares granted: 16,965 RSUs; price per share reported: $0.00; total reported cash value: $0.
- Footnote: F1 — Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
- Shares owned after transaction: Not specified in the provided filing details.
- No indication in the provided data that this was part of a 10b5-1 plan, tax withholding, or a sale; filing timeliness (late/on-time) not indicated here.
Context
- RSU awards are a form of compensation that typically vest over time or upon meeting performance conditions; they do not require the insider to pay cash at grant. They are not an immediate market purchase and therefore are not a direct bullish or bearish trading signal by themselves. For retail investors, such grants are common for executive/director compensation and should be evaluated along with vesting terms, company performance, and total insider holdings if available.
Insider Transaction Report
Form 4
MICHEL GERARD J
Director
Transactions
- Award
Common Stock
[F1]2026-05-21+16,965→ 33,509 total
Footnotes (1)
- [F1]Represents restricted stock unit award granted under the Issuer's 2025 Equity Incentive Plan.
Signature
/s/ Stephen Feider, Attorney-in-Fact|2026-05-26